Jonathan McNeill

2023

In 2023, Jonathan McNeill earned a total compensation of $2.2M as Chief Business Officer at Dyne Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$230,880
Option Awards$522,287
Salary$430,468
Stock Awards$1,046,199
Other$996
Total$2,230,830

McNeill received $1M in stock awards, accounting for 47% of the total pay in 2023.

McNeill also received $230.9K in non-equity incentive plan, $522.3K in option awards, $430.5K in salary and $996 in other compensation.

Rankings

In 2023, Jonathan McNeill's compensation ranked 461st out of 3,006 executives tracked by ExecPay. In other words, McNeill earned more than 84.7% of executives.

ClassificationRankingPercentile
All
461
out of 3,006
85th
Division
Manufacturing
265
out of 1,650
84th
Major group
Chemicals And Allied Products
181
out of 918
80th
Industry group
Drugs
178
out of 881
80th
Industry
Pharmaceutical Preparations
111
out of 637
83rd
Source: SEC filing on April 5, 2024.

McNeill's colleagues

We found two more compensation records of executives who worked with Jonathan McNeill at Dyne Therapeutics in 2023.

2023

Josh Brumm

Dyne Therapeutics

Chief Executive Officer

2023

Susanna High

Dyne Therapeutics

Chief Operating Officer

News

You may also like